Carboxymethylcellulose Sodium
Basic Information
| Item | Value |
|---|---|
| DrugBank ID | DB11059 |
| Evidence Level | L5 (Computational Prediction) |
| Number of Predicted Indications | 17 |
Predicted Indications (TxGNN)
The following are potential new indications predicted by the TxGNN model. Higher scores indicate higher predicted relevance.
| # | Indication | Source |
|---|---|---|
| 1 | irritable bowel syndrome | KG + DL |
| 2 | open-angle glaucoma | KG + DL |
| 3 | primary hereditary glaucoma | KG + DL |
| 4 | congenital hypotrichosis milia | KG + DL |
| 5 | alopecia | KG + DL |
| 6 | hypotrichosis simplex of the scalp | KG + DL |
| 7 | diffuse alopecia areata | KG + DL |
| 8 | cauda equina syndrome | KG + DL |
| 9 | gastroenteritis | KG + DL |
| 10 | enterocolitis (disease) | KG + DL |
| 11 | bile duct neoplasm | KG + DL |
| 12 | headache disorder | KG + DL |
| 13 | small intestine cancer | KG + DL |
| 14 | large intestine disease | KG + DL |
| 15 | biliary tract disease | KG + DL |
| 16 | small intestine disease | KG + DL |
| 17 | endolymphatic hydrops | KG + DL |
Disclaimer
These predictions are for research purposes only and do not constitute medical advice. Clinical validation is required before any clinical application.